A useful price comparison shows what happens after the first payment. This shortlist focuses on the selected plan, its recurring interval, and whether the provider is currently accepting clinical visits.

CoreAge Rx appears first as our featured commercial partner. The ordering is commercially determined, not a clinical ranking. Promise appears separately as an availability watch because its current page says visits are paused.

Keep this in mind

A useful price comparison shows what happens after the first payment. This shortlist focuses on the selected plan, its recurring interval, and whether the.

How we checked the offers

We used current official pages and visible browser checks on September 23, 2026. We did not enroll, obtain personalized quotes, or buy medication. Provider descriptions are not independently measured outcomes, and the FDA's compounding guidance remains relevant to every compounded option.

From $99/month. Advertised starting rate; confirm prepayment, supply, and renewal.

The product page describes no membership fees, free delivery, and online care. Its help center also discusses plans covering more than one month. Those statements can coexist: a monthly equivalent does not necessarily mean that only one month is charged today. Ask which offer applies to the exact prescription being considered and whether a consultation or laboratory work creates a separate expense. Ask: Does the $99 starting offer apply to my prescription, and what exact amount is charged now and at renewal? Read the CoreAge Rx review and official offer with additional provider details.

2. Pallas Health

$139 introductory month. Then $597 every 12 weeks under the displayed offer. Other plans have separate terms. The product FAQ limits this program to adults age 55 and under; prescribing and state availability require confirmation.

The displayed offer is $139 for the introductory month, then $597 every 12 weeks. Pallas describes provider care, medication when prescribed, messaging, and shipping within the plan; confirm the selected terms and any required services. Ask: Am I eligible for this particular program, and what are my first charge, next renewal date, and cancellation cutoff? Read the Pallas Health review and official offer with additional provider details.

Availability watch: Promise — visits paused

Visits paused; waitlist only. Live page checked September 23, 2026 says a prescriber-network transition has paused visits. No current purchasable price or reopening date was verified. Search-indexed prices are not treated as active offers.

The live product page is a waitlist, with no verified current purchase price or reopening date. Older search results still contain prices; those were excluded from the current offer comparison. Ask: Have clinical visits actually reopened, and which clinician, pharmacy, price, and follow-up terms now apply? Read the Promise review and official offer with additional provider details.

Compare the payment you will actually make

Keep a starting price, an introductory discount, and a renewal charge on different lines. Then add the period each payment covers. If the selected plan has not been confirmed, do not substitute the least expensive figure appearing elsewhere on the website.

Our introductory-price guide and 12-week billing explanation show why that precision matters. Pallas's terms provide a current example of plan-dependent recurring billing.

Check access and cancellation together

Ask whether the service can assess you, what happens if prescribing is inappropriate, and which future charges stop when you cancel. A published age policy or enrollment pause can make a price irrelevant to your immediate plans.

The CoreAge versus Pallas comparison considers these questions directly. For Promise, wait for a confirmed reopening and new terms before treating an older indexed price as an active offer.

A financial comparison supports planning; it cannot decide whether sermorelin is appropriate. Bring questions about the treatment itself to a clinician and the actual preparation to the dispensing pharmacist.

The source notes

Sources & further reading

Provider pages document advertised offers, not independently proven outcomes. Historical references may concern different products or uses. Check the dated discussion in each article for the scope of our research; offers can change.

  1. FDA's compounding guidance
  2. official offer
  3. additional provider details
  4. official offer
  5. additional provider details
  6. official offer
  7. additional provider details